"We Envision Growth Strategies Most Suited
to Your Business"
The global hormonal contraceptives market size is expected to gain momentum by reaching USD 24,330.1 million by 2027. This information is published by Fortune Business Insights in its latest report, titled, “Hormonal Contraceptives Market Size, Share & COVID-19 Impact Analysis, By Product (Pills, Injectable, Vaginal Rings, Intrauterine Devices, Implants, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Channel, Public Channel & NGOs, and Others), and Regional Forecast, 2020-2027.” The report further mentions that the market stood at USD 17,620.9 million in 2019 and is projected to exhibit a CAGR of 5.4% between 2020 and 2027.
Prasco Launches Authorized Generic NuvaRing to Brighten its Market Prospects
In December 2019, Prasco, a leading supplier of generic medical products, announced the launch of an authorized generic NuvaRing. According to the company, the etonogestrel/ethinyl estradiol vaginal ring is a flexible and small vaginal ring for women to prevent pregnancy. Moreover, the company reports that the product is expected to be available across stores and the patients can find the contraceptive in the nearby pharmacies with the help of product locator tool available at AuthorizedGenerics.com. Such initiatives by companies are likely to bode well for the growth of the global market for these contraceptives.
To get a detailed report summary and research scope of this market, click here:
https://www.fortunebusinessinsights.com/hormonal-contraceptives-market-102078
Increasing Prevalence of Unwanted Pregnancies to Aid Growth
According to the data by the Guttmacher Institute, around 5% of reproductive-age women go through unwanted pregnancy annually. The rate is considerably higher in the United States compared to other developed countries. The increasing incidence of unwanted pregnancy is expected to boost the adoption of innovative and effective hormonal contraceptives that is likely to contribute to the market growth in the forthcoming years. Moreover, the introduction of easy-to-use and efficient contraceptives is likely to bode well for the growth of the market.
Major Companies Focus on Investment in R&D Activities to Strengthen Their Market Positions
The global hormonal contraceptives market is consolidated by the presence of prominent companies focusing on investing in the development of advanced contraceptives to cater to the growing healthcare demand. Additionally, adoption of organic and inorganic strategies by other key players to gain a major chunk of the market share is projected to bode well for the market growth during the forecast period.
Industry Development:
List of the Companies Profiled in the Global Market:
Further Report Findings:
Table of Segmentation:
ATTRIBUTE | DETAILS |
Study Period | 2016-2027 |
Base Year | 2019 |
Forecast Period | 2020-2027 |
Historical Period | 2016-2018 |
Unit | Value (USD Million) |
Segmentation | Product; Distribution Channel; and Region |
By Product
|
|
By Distribution Channel
|
|
By Geography
|
|